Medicare Enrolled
Dr. Eric Mann, MD
Ophthalmology · Dover, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mann?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mann
Dr. Eric Mann is an ophthalmology specialist in Dover, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mann performed 10,122 Medicare services across 6,255 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mann received a total of $528,682 from 52 pharmaceutical and/or device companies across 1438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NJ
$528,682 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,122
Medicare services
Top 10% in NJ for ophthalmology
6,255
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~506 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
2,040 | $72 | $250 |
| Microfluid analysis of tears A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes. |
2,030 | $22 | $50 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
1,182 | $31 | $300 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
801 | $102 | $300 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
556 | $23 | $200 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
438 | $27 | $200 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
436 | $49 | $200 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
404 | $57 | $200 |
| Injection, bimatoprost, intracameral implant, 1 microgram | 370 | $155 | $250 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
227 | $34 | $200 |
| Corneal topography and eye depth measurement This procedure measures the curvature and depth of the cornea, the clear front surface of the eye. |
218 | $32 | $250 |
| Cataract surgery with lens implant Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision. |
189 | $430 | $2,500 |
| Insertion of drug delivery implant into tear duct A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time. |
140 | $14 | $200 |
| Amniotic membrane placement on eye surface This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing. |
137 | $1,225 | $2,500 |
| Laser removal of recurring cataract A laser procedure to remove a recurring cataract within the lens capsule. |
133 | $292 | $900 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
131 | $57 | $350 |
| Retinal and optic nerve function test A diagnostic test that measures how well the retina and optic nerve are functioning. |
119 | $112 | $300 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
106 | $113 | $300 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
102 | $211 | $1,500 |
| Eye photography Photographic imaging of the interior structures of the eye. |
94 | $20 | $150 |
| Ultrasound scan of cornea to determine thickness An ultrasound procedure used to measure the thickness of the cornea. |
78 | $9 | $125 |
| Medication injection into the eye A procedure involving the injection of medication directly into the eye. The specific type of medication or clinical purpose is not defined in the provided description. |
35 | $149 | $500 |
| Laser eye fluid drainage tract creation A laser procedure used to create drainage tracts in the iris to help fluid flow out of the eye. |
31 | $268 | $1,500 |
| Eyelid lining growth removal, larger than 1 cm Surgical removal of a growth located on the inner lining of the eyelid that measures more than 1.0 centimeter. |
24 | $399 | $1,000 |
| Incision to improve eye fluid flow A surgical procedure involving an incision to enhance the drainage of fluid within the eye. |
20 | $735 | $1,000 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
19 | $17 | $200 |
| Dilation of eye fluid drainage A procedure to widen the drainage pathways in the eye to help fluid flow out more easily. |
17 | $549 | $1,500 |
| Complex cataract removal with lens implant A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision. |
16 | $630 | $2,600 |
| Scar removal of eyelid lining Surgical removal of scar tissue from the inner lining of the eyelid caused by a previous infection. |
15 | $53 | $350 |
| Eyelid growth removal A procedure to remove a growth from the eyelid. |
14 | $255 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.9% high complexity
12.6% medium
85.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$528,682
Total received (2018-2024)
Avg $75,526/year across 7 years
Top 1% in NJ for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,438
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$475,666 (90.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$29,810 (5.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,206 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$83,867
2023
$122,820
2022
$166,672
2021
$89,652
2020
$13,017
2019
$34,976
2018
$17,678
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$50,547
ABBVIE INC.
$14,658
Ocular Therapeutix, Inc.
$5,036
Glaukos Corporation
$3,465
SUN PHARMACEUTICAL INDUSTRIES INC.
$3,088
BIOTISSUE HOLDINGS INC.
$2,447
NEW WORLD MEDICAL,INC.
$2,148
Sight Sciences, Inc.
$590
Dompe US, Inc.
$579
Alcon Vision LLC
$534
Tarsus Pharmaceuticals, Inc.
$222
Amgen Inc.
$139
Astellas Pharma US Inc
$123
Harrow Eye, LLC
$79
Oyster Point Pharma, Inc.
$63
Mallinckrodt Hospital Products Inc.
$52
LKC Technologies, Inc.
$32
Hollister Incorporated
$22
ABC Home Medical Supply, Inc.
$22
Carl Zeiss Meditec, Inc.
$21
Top 3 companies account for 83.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$160,734
Allergan, Inc.
$128,719
Bausch & Lomb Americas Inc.
$99,491
Allergan Inc.
$22,590
Bausch & Lomb, a division of Bausch Health US, LLC
$16,038
Shire North American Group Inc
$14,569
BIOTISSUE HOLDINGS, INC.
$12,282
Ocular Therapeutix, Inc.
$11,522
Mallinckrodt Hospital Products Inc.
$11,256
Aerie Pharmaceuticals, Inc.
$8,586
SUN PHARMACEUTICAL INDUSTRIES INC.
$7,113
Alcon Vision LLC
$6,484
Sun Pharmaceutical Industries Inc.
$5,095
Glaukos Corporation
$4,456
Dompe US, Inc.
$3,645
Oyster Point Pharma, Inc.
$2,585
BIOTISSUE HOLDINGS INC.
$2,447
NEW WORLD MEDICAL,INC.
$2,390
Sight Sciences, Inc.
$2,314
BioTissue Holdings, Inc.
$1,702
Kala Pharmaceuticals, Inc.
$1,529
Horizon Therapeutics plc
$375
Novartis Pharmaceuticals Corporation
$308
GLAUKOS CORPORATION
$280
Tarsus Pharmaceuticals, Inc.
$222
Astellas Pharma US Inc
$210
Alcon Laboratories Inc
$196
Eyevance Pharmaceuticals LLC
$158
Mallinckrodt Enterprises LLC
$142
Amgen Inc.
$139
RxSight Inc
$132
Harrow Eye, LLC
$122
Exeltis, USA Inc.
$118
Johnson & Johnson Surgical Vision, Inc.
$106
Coherus Biosciences Inc.
$97
Mallinckrodt LLC
$79
TISSUETECH, INC.
$78
ANI Pharmaceuticals, Inc.
$47
CooperVision Inc.
$39
TearLab Corp
$39
LKC Technologies, Inc.
$32
EYEVANCE PHARMACEUTICALS LLC
$29
EyePoint Pharmaceuticals US, Inc.
$27
Thea Pharma Inc.
$22
Hollister Incorporated
$22
ABC Home Medical Supply, Inc.
$22
Carl Zeiss Meditec, Inc.
$21
Rayner Intraocular Lenses Limited
$19
Apellis Pharmaceuticals, Inc.
$19
Omeros Corporation
$14
Genentech USA, Inc.
$14
OPTOS, INC.
$8
Top 3 companies account for 73.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · ALREX · AMINOGRAFT · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · BESIVANCE · BLINK NUTRITEARS · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · COMBIGAN · Cequa · Cimerli · Clareon · Clear Care · DAILIES TOTAL1 · DEXTENZA · DEXYCU · DURYSTA · EYSUVIS · Flarex · HYDRUS Microstent · IACCESS · IHEEZO · ILUX · INFUSE · INVELTYS · ISTENT INJECT W · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Izervay · Kahook Dual Blade · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · MEIBOMIAN GLAND EVALUATOR · MIEBO · MiSight Contact Lens · Monaco · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · ORA · OXERVATE · Omidria · Onli · Oxervate · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · PanOptix · RESTASIS · RESTASIS MULTIDOSE · Rocklatan · Simbrinza · Syfovre · TEARCARE SYSTEM · TEARLAB OSMOLARITY SYSTEM · TEPEZZA · TORIC · TRAVATAN Z · TYRVAYA · TearCare SmartLid · TearLab Osmolarity System · Tecnis 1-piece IOL · TobraDex ST · Tobradex ST · VABYSMO · VEVYE · VUITY · VYZULTA · XDEMVY · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · ZYLET · Zerviate · enVista MX60 IOL · iDose · iStent Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass Stent System · iStent inject W · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for ophthalmology in NJ.
Geographic Context
Ophthalmologists within 10 mi
244
Per 100K population
47.8
County median income
$134,929
Nearest hospital
SAINT CLARE'S HOSPITAL/ DENVILLE CAMPUS
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mann is a mixed practice specialist, with above-average Medicare volume (top 10% in NJ), with speaking/promotional industry engagement in the top 1% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mann experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Mann performed 2,040 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mann receive payments from pharmaceutical companies?
Yes. Dr. Mann received a total of $528,682 from 52 companies across 1,438 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mann's costs compare to other ophthalmologists in Dover?
Dr. Mann's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Dover
Browse ophthalmologists in Dover ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in NJ
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in NJ
Which NJ ophthalmologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Bausch & Lomb Americas Inc. Payments to Doctors
See all physicians who received payments from Bausch & Lomb Americas Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology